Prodermis Wins Best Hybrid Filler Innovation 2026 at The Anti-Aging and Corrective Dermatology Congress, Romania

International Recognition for the Next Generation of Dermal Fillers

We are proud to announce that Prodermis has been awarded Best Hybrid Filler Innovation 2026 at ‘The Aesthetic Medicine, Anti-Aging and Corrective Dermatology Congress, Bucharest, Romania’.

This award recognises the groundbreaking technology behind the Prodermis Prosculpt range, which combines advanced cross-linked hyaluronic acid with polynucleotides (PN) to create a unique hybrid dermal filler designed to deliver exceptional aesthetic outcomes.

As one of the first products globally to successfully integrate these technologies into a single filler platform, Prodermis continues to challenge conventional approaches to facial rejuvenation and aesthetic enhancement.

What Makes Prodermis Different?

Traditional dermal fillers have relied solely on hyaluronic acid to provide volume, projection and structural support.

Prodermis takes this concept further by combining premium cross-linked hyaluronic acid with polynucleotides, creating a unique hybrid filler designed to support both aesthetic performance and tissue quality.

The result is a product range developed to deliver:

  • Natural-looking volumisation
  • Excellent projection and structural support
  • Smooth integration within tissue
  • High patient satisfaction
  • Advanced rheological performance
  • A next-generation approach to facial rejuvenation

Recognition on an International Stage

Receiving the Best Hybrid Filler Innovation Award at a major European aesthetic exhibition is a significant milestone for the Prodermis brand.

The award reflects the dedication of our scientific, manufacturing and clinical partners who have worked tirelessly to develop a product that pushes the boundaries of what practitioners can expect from a dermal filler.

Innovation has always been at the heart of Prodermis, and this recognition further validates our commitment to advancing the aesthetics industry through science-led product development.

The Prosculpt Range

The award-winning Prosculpt range consists of:

Prosculpt Fine

Designed for fine lines, superficial correction and delicate facial areas.

Prosculpt Deep

Ideal for moderate facial folds, contouring and volume restoration.

Prosculpt Sub-Q

Developed for deeper structural support, projection and facial sculpting.

Each product is manufactured using advanced cross-linking technology and incorporates the unique Prodermis hybrid approach.

Looking Ahead

This award marks an exciting moment in the journey of Prodermis, but it is only the beginning.

As the brand continues its international expansion, we remain committed to delivering innovative products, practitioner education and scientific excellence to aesthetic professionals worldwide.

We would like to thank all of our partners, distributors, practitioners and supporters who have contributed to this achievement.

Together, we are shaping the future of aesthetic medicine.

Prodermis™ — Award-Winning Innovation. Clinically Inspired. Scientifically Advanced.

Category Post

Prodermis ProEye Illuminate Training Now Live

We are proud to announce the launch of the Prodermis ProEye Illuminate Training Course, now available on our new online training platform.

PRODERMIS PROSCULPT — Redefining the Science of Dermal Fillers

Prodermis Prosculpt is the first hybrid dermal filler to combine cross-linked Hyaluronic Acid with Polynucleotides in a patented formulation. This synergy delivers immediate volumisation and lift alongside progressive dermal regeneration, superior rheology, reduced injection force, and extended longevity of up to 56 weeks — redefining filler performance and clinical outcomes.

PRODERMIS at IMCAS Paris 2026: Introducing PROSCULPT™ and the New PRODERMIS Skincare Line